Personalized medicine in oncology: where have we come from and where are we going?

Author： André Fabrice   Ciccolini Joseph   Spano Jean-Philippe   Penault-Llorca Frédérique   Mounier Nicolas   Freyer Gilles   Blay Jean-Yves   Milano Gérard  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.14, Iss.8, 2013-06, pp. : 931-939

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hormone-Refractory Prostate Cancer: Where are We Going?

By Giuseppe Di Lorenzo  

Drugs, Vol. 67, Iss. 8, 2007-01 ,pp. : 1109-1124

Adis International

Access to resources Recommend Favorite

Where are we going with ulcerative colitis management?

By Odes Selwyn  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 1, 2013-03 ,pp. : 1-4

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics in clinical practice: how far have we come and where are we going?

By Johnson Julie A  

Pharmacogenomics, Vol. 14, Iss. 7, 2013-05 ,pp. : 835-843

Future Medicine

Access to resources Recommend Favorite

Paediatric Pharmacy in Australia: Where Have We Come From and Where Do We Need To Go?

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 43, Iss. 1, 2013-03 ,pp. : 45-48

John Wiley & Sons Inc

Access to resources Recommend Favorite

Insulin-like growth factor 1 receptor inhibitors: Where do we come from? What are we? Where are we going?

By Chmielowski Bartosz  

Cancer, Vol. 120, Iss. 16, 2014-08 ,pp. : 2384-2387

Blackwell Publishing

Access to resources Recommend Favorite